Literature DB >> 8337543

Evaluation of enzyme linked immunosorbent-assay and western blot for diagnosis of histoplasmosis.

M Torres1, H Díaz, T Herrera, E Sada.   

Abstract

This study evaluates the use of a enzyme linked immunosorbent assay (ELISA) for the diagnosis of histoplasmosis and it compares it with a complement fixation test. The results showed a sensitivity of 86% in this diagnosis of acute pulmonary histoplasmosis and specificity of 91% using anti-human IgG. For antihuman IgM the sensitivity was 66% and the specificity 100%. There was a good correlation between the titer of complement fixation test and the optical density index by ELISA. Neither ELISA or complement fixation were useful for the diagnosis of disseminated histoplasmosis in immunocompromised patients. Using Western blot we identified antibodies against four different histoplasma antigens (91, 83, 70 and 38 kD) in sera from patients with histoplasmosis. These antigens were identified also in patients with disseminated histoplasmosis. We conclude that ELISA is a useful test for the diagnosis of histoplasmosis, and the Western blot could be useful for the diagnosis of disseminated histoplasmosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8337543

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  6 in total

1.  Development of a novel antigen detection test for histoplasmosis.

Authors:  B L Gomez; J I Figueroa; A J Hamilton; B L Ortiz; M A Robledo; A Restrepo; R J Hay
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  DIAGNOSIS OF HISTOPLASMOSIS.

Authors:  Allan Jefferson Guimarães; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Braz J Microbiol       Date:  2006-01       Impact factor: 2.476

3.  Diagnostic Methods for Histoplasmosis: Focus on Endemic Countries with Variable Infrastructure Levels.

Authors:  Christina M Scheel; Beatriz L Gómez
Journal:  Curr Trop Med Rep       Date:  2014-04-08

4.  Disseminated histoplasmosis by Histoplasma capsulatum var. duboisii in a paediatric patient from the Chad Republic, Africa.

Authors:  A Garcia-Guiñon; J M Torres-Rodríguez; D Torangar Ndidongarte; F Cortadellas; L Labrín
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-13       Impact factor: 3.267

5.  Validation of western blot for Histoplasma capsulatum antibody detection assay.

Authors:  Marcos de Abreu Almeida; Cláudia Vera Pizzini; Lisandra Serra Damasceno; Mauro de Medeiros Muniz; Rodrigo Almeida-Paes; Regina Helena Saramago Peralta; José Mauro Peralta; Raquel de Vasconcelos Carvalhaes Oliveira; Alexandre Gomes Vizzoni; Carla Lourenço Tavares de Andrade; Rosely Maria Zancopé-Oliveira
Journal:  BMC Infect Dis       Date:  2016-02-24       Impact factor: 3.090

6.  Detection of anti-Histoplasma capsulatum antibodies and seroconversion patterns in critically ill patients with COVID-19: An underdiagnosed fungal entity complicating COVID-19?

Authors:  María A Toscanini; Fernanda Barberis; María F Benedetti; Agustín Videla Garrido; Gladys B Posse; Paula Capece; Gabriela López Daneri; Alejandro D Nusblat; María L Cuestas
Journal:  Med Mycol       Date:  2022-03-04       Impact factor: 4.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.